KeyBanc Upgrades Acadia Healthcare (ACHC) to Overweight

KeyBanc analyst Matthew Gillmor upgraded Acadia Healthcare (NASDAQ: ACHC) from Sector Weight to Overweight with a price target of $70.00.

The analyst comments: "We think ACHC's stock could inflect meaningfully higher during 2025, as investors gain visibility into the potential 2026 EBITDA acceleration. In our view, 2026 EBITDA will benefit from the maturation of 2024-2025 bed adds and moderating startup costs. While our revised 2025 EBITDA estimate is below Street (KBCM at $735M vs. Street $770M), we think buy-side is already there and this may provide a good backdrop to establish conservative guidance. Additionally, we think valuation can begin to normalize during 2025 (to >9x), as negative press headlines from 2024 fade and 2026 EBITDA comes into focus."

For an analyst ratings summary and ratings history on Acadia Healthcare click here. For more ratings news on Acadia Healthcare click here.

Shares of Acadia Healthcare closed at $44.85 yesterday.

You May Also Be Interested In